Similar associations between reduced CD9, greater invasiveness, and metastatic potential are reported in laryngeal squamous cell carcinoma (LSCC) and esophageal squamous cell carcinoma (ESCC) [62]. Here, CD9 is linked to esophageal squamous cell carcinoma.